V. Kretschmer , A. See , D. Söhngen , M. Bachem , J.G. Kadar , H. Borberg , H. Pelzer , P. Zöfel
{"title":"First results with the new Fresenius cell separator AS 104","authors":"V. Kretschmer , A. See , D. Söhngen , M. Bachem , J.G. Kadar , H. Borberg , H. Pelzer , P. Zöfel","doi":"10.1016/S0278-6222(87)80035-9","DOIUrl":null,"url":null,"abstract":"<div><p>In the last few years Fresenius has developed a new cell separator. The intention was to improve the existing systems by taking advantage of the extensive worldwide experience of cell separation in the past years. The first prototypes of this cell separator AS 104 were set up in Marburg and in Cologne. In a pilot study we performed 25 procedures with 2 to 3 liters of fresh whole blood. These results will not be considered here. We now present the results from the first clinical trial.</p></div>","PeriodicalId":101030,"journal":{"name":"Plasma Therapy and Transfusion Technology","volume":"8 4","pages":"Pages 298-301"},"PeriodicalIF":0.0000,"publicationDate":"1987-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0278-6222(87)80035-9","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasma Therapy and Transfusion Technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278622287800359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15
Abstract
In the last few years Fresenius has developed a new cell separator. The intention was to improve the existing systems by taking advantage of the extensive worldwide experience of cell separation in the past years. The first prototypes of this cell separator AS 104 were set up in Marburg and in Cologne. In a pilot study we performed 25 procedures with 2 to 3 liters of fresh whole blood. These results will not be considered here. We now present the results from the first clinical trial.